A shortage of later stage projects is forcing companies hunt further down the drug discovery ladder. Now the Wellcome Trust is injecting charitable money to fill the holes.
For European tech start-ups, 2006 was the year that the traffic lights for money switched from red to yellow. Yet to be seen is whether they finally go green next year.
Microsoft France's support scheme for start-ups has begun its second year, with success at just one of the 25 companies it has helped covering the costs of the programme over two years. And now Microsoft’s subsidiaries in Germany and the UK are joining in.
Who should profit from cutting-edge academic research: the scientists or the institution that funds them? Both, in a new biotech company launched by one of Sweden’s leading researchers.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.